5-HYDROXYTRYPTAMINE(1A) RECEPTOR SYNTHETIC PEPTIDES - MECHANISMS OF ADENYLYL-CYCLASE INHIBITION

被引:0
|
作者
VARRAULT, A
LENGUYEN, D
MCCLUE, S
HARRIS, B
JOUIN, P
BOCKAERT, J
机构
[1] CNRS,UPR 9023,F-34094 MONTPELLIER 05,FRANCE
[2] MARION MERRELL DOW RES INST,STRASBOURG RES CTR,F-67046 STRASBOURG,FRANCE
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 5-hydroxytryptamine(1A) receptor (5-HT(1A)R) is a G-protein-coupled receptor negatively coupled to adenylyl cyclase (AC). We have studied the functional domains of 5-HT(1A)R using synthetic peptides to block or mimic receptor function. The entire second intracellular loop (5-HT(1A)R-i(2)) and the carboxyl end of the third intracellular loop (5-HT(1A)R-i(3)-C) strongly inhibited forskolin-stimulated AC activity. These effects were not additive with those of 5-HT. Like 5-HT, the peptides 5-HT(1A)R-i(3)-C and -i(2) weakly inhibited AlF4- and Mn2+ stimulated AC activity. 5-HT(1A)R binding assays indicated that peptides could interact with the same G-protein pool as the 5-HT(1A)R. 5-HT(1A)R-i(3)-C- and -i(2)-stimulated [S-35]guanosine 5'-O-(thiotriphosphate) binding on G(o)/G(i) proteins. Only 5-HT(1A)R-i(3)-C partially adopted an alpha-helical conformation in solution. These data show that different domains in the 5-HT(1A)R second and third intracellular loops can couple to and activate G(i) proteins in order to mediate AC inhibition. Peptide-induced AC inhibition was not sensitive to pertussis toxin as opposed to the 5-HT(1A)R-mediated effect. Our data show that the 5-HT(1A)R and the 5-HT(1A)R peptides activate G(i) proteins in a slightly different manner.
引用
收藏
页码:16720 / 16725
页数:6
相关论文
共 50 条
  • [31] Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation
    Nakayama, Hiroto
    Umeda, Sumiyo
    Nibuya, Masashi
    Terao, Takeshi
    Nisijima, Koichi
    Nomura, Soichiro
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 283 - 286
  • [32] Mapk activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of Xaliproden
    Appert-Collin, A
    Duong, FHT
    Degrace, PP
    Warter, JM
    Poindron, P
    Gies, JP
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (01): : 21 - 31
  • [33] Synthetic peptides of the α subunit of Gs protein inhibit receptor mediated adenylyl cyclase
    Rovero, P
    Galoppini, C
    Taddei, S
    Giusti, L
    Mazzoni, MR
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 587 - 588
  • [34] ADENOSINE RECEPTOR-MEDIATED INHIBITION OF CARDIAC ADENYLYL-CYCLASE ACTIVITY MAY INVOLVE MULTIPLE RECEPTOR SUBTYPES
    MA, H
    YU, HJ
    GREEN, RD
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 349 (01) : 81 - 86
  • [35] Specific inhibition of adenylyl-cyclase isoform 5 by mood stabilizers may be related to their mechanism of action
    Liad Mann
    Eliahu Heldman
    Yuly Bersudsky
    Orna Almog
    RH Belmaker
    Galila Agam
    Annals of General Psychiatry, 9 (Suppl 1)
  • [36] Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms
    Egashira, Nobuaki
    Okuno, Ryoko
    Matsushita, Michihiko
    Abe, Moe
    Mishima, Kenichi
    Iwasaki, Katsunori
    Nishimura, Ryoji
    Oishi, Ryozo
    Fujiwara, Michihiro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 592 (1-3) : 103 - 108
  • [37] Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors
    Lin, Q
    Peng, YB
    Willis, WD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 276 (03): : 958 - 967
  • [38] Ultrastructural localization of 5-hydroxytryptamine(1A) receptors in the rat brain
    Kia, HK
    Brisorgueil, MJ
    Hamon, M
    Calas, A
    Verge, D
    JOURNAL OF NEUROSCIENCE RESEARCH, 1996, 46 (06) : 697 - 708
  • [39] 5-hydroxytryptamine 1A receptors, major depression, and suicidal behavior
    Pitchot, W
    Hansenne, M
    Pinto, E
    Reggers, J
    Fuchs, S
    Ansseau, M
    BIOLOGICAL PSYCHIATRY, 2005, 58 (11) : 854 - 858
  • [40] The pharmacological characterization of a novel selective 5-hydroxytryptamine(1A) receptor antagonist, NAD-299
    Johansson, L
    Sohn, D
    Thorberg, SO
    Jackson, DM
    Kelder, D
    Larsson, LG
    Renyi, L
    Ross, SB
    Wallsten, C
    Eriksson, H
    Hu, PS
    Jerning, E
    Mohell, N
    WestlindDanielsson, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 283 (01): : 216 - 225